KRAS and colorectal carcinoma: A new study indicates that a type of natural product, β-elemene, is a novel ferroptosis inducer that can improve the sensitiveness of KRAS mutant CRC cells combined with cetuximab by promoting ferroptosis and suppressing EMT [79].